Reporting owner · CIK 0002030840

Heltzen Michael

Visual SEC Form 4 history across 2 companies, 8 transactions and 2 filings.

CEOChief Executive OfficerEXOZYMES INC.
Open-market mix
Filings2Form 4 records
Buying$26.8K7 purchases
Selling$00 sales
Net value$26.8KBuys minus sells
Companies21 securities
Most recentAug 26, 2026buy

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for some of their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-52Jan 255Aug 26

Net value flow

Buys minus sells

Jan 25
$20.3K
Aug 26
$6.4K

Transaction texture

Ownership and ticket size

Average P/S size$3.8K
Median P/S size$1.8K
Direct8
Indirect0
Aug 26, 2026buy

Filing-only signals

Deterministic matches in this insider's history

Latest Form 4 facts

Quick context from source filings

Latest transaction

buy at EXOZYMES INC. on Aug 26, 2026 valued at $1,900.

Review SEC filing
Latest sale

No open-market insider sale is available.

Heltzen Michael Insider Activity FAQ

SEC Form 4 context

Who is Heltzen Michael?

Heltzen Michael is a reporting owner in SEC Form 4 filings with reporting owner CIK 0002030840.

Which companies has Heltzen Michael reported transactions for?

EXOZYMES INC., Invizyne Technologies Inc

When was Heltzen Michael's latest insider buy?

buy at EXOZYMES INC. on Aug 26, 2026 valued at $1,900.

When was Heltzen Michael's latest insider sale?

No open-market insider sale is available for this period.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.